￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest price and medical insurance coverage of Pazopanib in 2025

2026-02-01 22:25:32

Check Details
Full analysis of Opicapone adverse reactions and treatment

2026-02-01 22:25:32

Check Details
Why Fenelidone Tablets (Keshenda) is called a banned drug and its usage restrictions

2026-02-01 22:25:32

Check Details
Rasagiline (Azila) usually takes a few days to see initial effects.

2026-02-01 22:25:32

Check Details
Are the symptoms of insomnia normal after taking Leborexan (Daveco) and suggestions for treatment?

2026-02-01 22:25:32

Check Details
The best time to take Mavakatai (Mafantuo) and suggestions for matching it with diet and rest

2026-02-01 22:25:32

Check Details
Reasons why patients with hepatitis B are not recommended to use tenofovir alafenamide tablets (Vemlidy)

2026-02-01 22:25:32

Check Details
Precautions and safety suggestions while taking vorasidenib-VORANIGO

2026-02-01 22:25:32

Check Details
Analysis of the pharmacological action mechanism and therapeutic principle of eflornithine (IWILFIN)

2026-02-01 22:25:32

Check Details
Important precautions and safety guidance during use of odexibat (Belvi)

2026-02-01 22:25:32

Check Details
The efficacy data of Erdafitinib has been released, and the price difference between domestic and foreign countries is huge. How should patients choose?

2026-02-01 22:25:32

Check Details
Talazoparib 2025 medical insurance reimbursement policy

2026-02-01 22:25:32

Check Details
Category
相关知识